Pegcetacoplan
APL2-203
Phase 2 small_molecule terminated
Quick answer
Pegcetacoplan for Neovascular Age-related Macular Degeneration is a Phase 2 program (small_molecule) at Apellis Europe B.V. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Apellis Europe B.V.
- Indication
- Neovascular Age-related Macular Degeneration
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated